Symantec Endpoint Protection (Windows) agent may be susceptible to a Privilege Escalation…
Priority MEDIUM 44Published · Updated
Key facts
- Attack vector
- Network
- Privileges required
- None
- User interaction
- None
- Attack complexity
- Low
- Impact type
- —
- Confidentiality · integrity · availability
- High · High · High
- Fix status
- No fix listed
Attack profile from CVSS 3.1 · CISA ADP. Fix status from CNA.
Summary
Symantec Endpoint Protection (Windows) agent may be susceptible to a Privilege Escalation vulnerability, which is a type of issue whereby an attacker may attempt to compromise the software application to gain elevated access to resources that are normally protected from an application or user.
Why it matters now
Exploitation None reported CISA SSVC · not in CISA KEV
EPSS 0.00736 54th percentileScored 2026-11-07
Fix No fix listed No fixed version in the sources yet
SSVC decision points
CISA ADP · SSVC 2.0.3
- Exploitation
- None
- Automatable
- No
- Technical impact
- Total
The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.
Affected products
| Vendor | Product | Affected versions | Fixed in | Status | Source |
|---|---|---|---|---|---|
| — | Symantec Endpoint Protection | 14.3 RU5 | — | No fix listed | CNA |
- Symantec Endpoint Protection Vendor— Affected 14.3 RU5 Fixed in — No fix listed CNA
Remediation
No fixed version listed by the sources yet.
Timeline
- 2026-10-02 Threatist record created from CVE-2022-37016
- 2026-10-03 Alias added: GHSA-xf35-ghx9-6hhf
References
More Broadcom Symantec Endpoint Protection vulnerabilities
- TI-2022-17221 Symantec Endpoint Protection (Windows) agent, prior to 14.3 RU6/14.3 RU5 Patch 1, may be… CVSS 3.1HIGH 7.5
- TI-2022-09219 Improper privilege management in Symantec Endpoint Protection CVSS 3.1HIGH 7.8
Sources
- CVE-2022-37016 · CVE Program
- CVE-2022-37016 · NVD
- FIRST EPSS
- GHSA-xf35-ghx9-6hhf · GitHub Advisory Database · CC BY 4.0
This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences